Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 2, 2026, 8:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–20 of 20 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Onabotulinumtoxin A (BoNT) Clear all

Conditions: Frown Lines
Interventions: Botulinum toxin A "BoNT/A-DP", Botulinum toxin A "Botox Cosmetics"; Biological
Lead sponsor: Croma-Pharma GmbH; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 208 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Santa Monica, California • Coral Gables, Florida

Conditions: Upper Limb Spasticity
Interventions: Botulinum toxin type A, BoNT-A, Rehabilitation Therapy; Drug · Other
Lead sponsor: JoAnn Harnar; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Glabellar Frown Lines (GL), Lateral Canthal Lines (LCL)
Interventions: botulinum toxin neuromodulator, Placebo; Biological
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 413 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 11
States / cities: Encino, California • Santa Monica, California • West Hollywood, California + 8 more

Conditions: Glabellar Frown Lines
Interventions: botulinum toxin, Placebo; Biological
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 13
States / cities: Manhattan Beach, California • Vista, California • New Orleans, Louisiana + 8 more

Conditions: Prostate Cancer, Benign Prostatic Hyperplasia, Enlarged Prostate With Lower Urinary Tract Symptoms (LUTS)
Interventions: BOTOX; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 50 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Spinal Cord Injuries
Interventions: Bladder chemodenervation (Botox), Bladder Sham (Saline) Injection Procedure; Drug · Procedure
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Glabellar Frown Lines
Interventions: Botulinum Toxin A, Placebo; Drug
Lead sponsor: Croma-Pharma GmbH; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 410 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Overactive Bladder, Urinary Urge Incontinence, Urinary Bladder, Neurogenic, Painful Bladder Syndrome
Interventions: Onabotulinumtoxin A (BoNT), belladonna, Morphine, Placebo, Active B&O suppository of belladonna; Drug
Lead sponsor: Edgar LeClaire, MD; Other
Eligibility: 18 Years and older · Female only
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Wichita, Kansas

Conditions: Endometriosis, Chronic Pelvic Pain, Pelvic Muscle Spasm, Quality of Life
Interventions: Botulinum toxin (BoNT), Placebo; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Essential Tremor
Interventions: Botulinum toxin, Placebo; Drug · Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Glabellar Frown Lines
Interventions: Botulinum Toxin A, Placebo, Botulinum Toxin A - Open Label; Drug
Lead sponsor: Croma-Pharma GmbH; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 251 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 7
States / cities: Encinitas, California • Aventura, Florida • Sarasota, Florida + 4 more

Conditions: Cervical Dystonia
Interventions: Botulinum toxin type A; Biological
Lead sponsor: Ipsen; Industry
Eligibility: 18 Years and older
Enrollment: 1,050 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 4
States / cities: Elkridge, Maryland • Boston, Massachusetts • Southfield, Michigan + 1 more

Conditions: Glabellar Frown Lines
Interventions: QM1114-DP, Placebo; Biological
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 9
States / cities: Homewood, Alabama • Manhattan Beach, California • Vista, California + 6 more

Conditions: Traumatic Brain Injury
Interventions: BoNT A; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Glabellar Frown Lines
Interventions: Botulinum Toxin A, Placebo; Drug
Lead sponsor: Croma-Pharma GmbH; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 784 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 9
States / cities: Birmingham, Alabama • Encino, California • San Francisco, California + 6 more

Conditions: Lateral Canthal Lines
Interventions: botulinum toxin, Placebo; Biological
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 303 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 8
States / cities: Manhattan Beach, California • San Diego, California • Solana Beach, California + 5 more

Conditions: Spasmodic Dysphonia, Dystonia
Interventions: Vocal Exercise; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Torticollis, Dystonia
Interventions: CBT; Behavioral
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 75 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Neuropathic Pain
Interventions: onabotulinum toxin A; Drug
Lead sponsor: Isabel Moreno Hay; Other
Eligibility: 18 Years to 80 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Benign Prostatic Hyperplasia
Interventions: botulinum toxin type A (BoNT/A); Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 50 Years and older · Male only
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 7
States / cities: Denver, Colorado • Chicago, Illinois • Rochester, Minnesota + 4 more

Search by objective public record fields.

Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines

Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Treatment of Moderate to Severe Glabellar Lines

BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)

Early BOTOX After Spinal Cord Injury

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)

Reduction of Bladder Injection Pain With Belladonna Opiate Suppository

Botulinum Toxin for Pelvic Pain in Women With Endometriosis

Comparison of Botulinum Toxin Injections in Forearm FLexor Plus EXtensor Muscles vs. Flexor Muscles Alone for Treatment of Essential Hand Tremor(FLEX-D ET)

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II

Phase IV-Cervical Dystonia-INTEREST IN CD2

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I

Treatment of Moderate to Severe Lateral Canthal Lines

Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia

OnabotulinumtoxinA in the Management of Psychogenic Dystonia

Intraoral Administration of Botox in Patients With Dentoalveolar Neuropathic Pain

Botulinum Toxin Injection for the Management of BPH